Probiovita is a modular platform by Probiovita UAB designed for medical research and health management scenarios. It aims to help medical experts, researchers, hospitals, and clinics collect high-quality health data faster and enhance interaction between doctors/patients or researchers/participants via web and mobile platforms. Key scenarios include real-time clinical trial analysis, treatment plan efficacy evaluation, chronic disease management, and prevention and outbreak early warning.
The platform emphasizes building mobile and web solutions on demand. In clinical trial scenarios, participants can use the mobile app to record data on symptoms, medications, supplements, exercise, habits, and nutrition; designated professionals can monitor them via web access and set up alerts to detect early signals of adverse health events. The system also supports setting different treatment plans for different participant groups, adding, editing, and deleting modules required for research, and integrating AI analysis modules to accelerate research findings and insight generation.
Regarding third-party integration, the website only explicitly mentions that third-party APIs can be added to collect data from approved devices, but it does not list specific devices, API documentation, or developer tools. For collaboration permissions, the terms mention that data is only accessible to authorized users, and clinical professionals can monitor assigned participants, but it does not disclose granular role-based access controls, audit logs, or organizational management capabilities. In terms of security compliance, the text mentions handling user data confidentially and references HIPPA/HIPAA-related content in the Privacy Policy, but lacks proof of encryption, certification, or ISO/SOC compliance.
The website does not publicly disclose plans, unit prices, or per-user/per-project billing methods; it only offers "Get A Quote" and "Request Demo," indicating a preference for project-based or custom pricing. Deployment options are only reflected as website, mobile features, and web-based access, with no mention of whether self-hosted deployment, data residency, or cloud region selection is supported.
Pros include a clear medical vertical focus, high modularity, coverage of both patient-side data collection and professional-side monitoring, and an emphasis on real-time analytics and AI. The main con is the lack of publicly available information; pricing, implementation, compliance, security, and customer cases all require further verification. It is more suitable for medical research organizations with needs for customized clinical research, remote data collection, chronic disease management, or public health early warning, rather than general SaaS buyers looking for out-of-the-box, transparently priced, and mature ecosystems.
There is no information regarding access from China; network connectivity, payment methods, and local compliance support are all unknown. If conducting medical data projects in China, one must carefully evaluate cross-border data transfer, MLPS (Multi-Level Protection Scheme), personal information protection, and medical data compliance requirements. Alternatives to consider include REDCap, Medidata, Castor EDC, Veeva Clinical, as well as domestic cloud providers or local clinical data collection and chronic disease management systems.
โ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on probiovita.com official site.
probiovita.com is an Unknown SaaS Tools provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach probiovita.com directly.